Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer.
Sci Transl Med
; 14(660): eabj1531, 2022 08 31.
Article
in En
| MEDLINE
| ID: mdl-36044597
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lung Neoplasms
/
Neuralgia
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Sci Transl Med
Year:
2022
Document type:
Article